Addis A - Search Results

1

Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey.

Bertolini G, Rossi C, Anghileri A, Livigni S, Addis A, Poole D. Bertolini G, et al. Among authors: addis a. Intensive Care Med. 2007 Mar;33(3):426-34. doi: 10.1007/s00134-007-0554-x. Epub 2007 Feb 15. Intensive Care Med. 2007. PMID: 17325836

2

Drotrecogin alfa (activated) in severe sepsis.

Poole D, Rossi C, Addis A, Livigni S, Bertolini G. Poole D, et al. Among authors: addis a. Lancet Infect Dis. 2013 Feb;13(2):107-8. doi: 10.1016/S1473-3099(12)70325-0. Lancet Infect Dis. 2013. PMID: 23347624 No abstract available.

3

Can systematic reviews contribute to regulatory decisions?

Barbui C, Addis A, Amato L, Traversa G, Garattini S. Barbui C, et al. Among authors: addis a. Eur J Clin Pharmacol. 2017 Apr;73(4):507-509. doi: 10.1007/s00228-016-2194-y. Epub 2017 Jan 7. Eur J Clin Pharmacol. 2017. PMID: 28064354 Review.

4

Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies.

Addis A, Koren G. Addis A, et al. Psychol Med. 2000 Jan;30(1):89-94. doi: 10.1017/s0033291799001270. Psychol Med. 2000. PMID: 10722179

5

Can we use anxiolytics during pregnancy without anxiety?

Addis A, Dolovich LR, Einarson TR, Koren G. Addis A, et al. Can Fam Physician. 2000 Mar;46:549-51. Can Fam Physician. 2000. PMID: 10751993 Free PMC article.

6

Informing women about drugs they take during pregnancy: promoting consumers' drug information as integral part of care.

Bonati M, Addis A. Bonati M, et al. Among authors: addis a. Pharm World Sci. 1998 Dec;20(6):236-7. doi: 10.1023/a:1008623722238. Pharm World Sci. 1998. PMID: 9972523

7

Meta-analytic review of the clinical effectiveness of oral deferiprone (L1).

Addis A, Loebstein R, Koren G, Einarson TR. Addis A, et al. Eur J Clin Pharmacol. 1999 Mar;55(1):1-6. doi: 10.1007/s002280050584. Eur J Clin Pharmacol. 1999. PMID: 10206077

8

Risk classification systems for drug use during pregnancy: are they a reliable source of information?

Addis A, Sharabi S, Bonati M. Addis A, et al. Drug Saf. 2000 Sep;23(3):245-53. doi: 10.2165/00002018-200023030-00006. Drug Saf. 2000. PMID: 11005706

9

Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy.

Trotta F, Belleudi V, Fusco D, Amato L, Mecozzi A, Mayer F, Sansone M, Davoli M, Addis A. Trotta F, et al. Among authors: addis a. BMJ Open. 2017 Mar 10;7(3):e011637. doi: 10.1136/bmjopen-2016-011637. BMJ Open. 2017. PMID: 28283484 Free PMC article.

10

Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region.

Trotta F, Mayer F, Mecozzi A, Amato L, Addis A. Trotta F, et al. Among authors: addis a. BioDrugs. 2017 Apr;31(2):117-124. doi: 10.1007/s40259-017-0214-9. BioDrugs. 2017. PMID: 28353170 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page